Rare diseases
Investigational molecules
Locations
Eisenbahnstrasse 63, Suedstadt, 72072 Tuebingen, Germany
HepaRegeniX GmbH’s clinical research is centered on colon carcinoma metastases involving the liver, with a focus on patients who have undergone liver surgery for metastatic disease. The sponsor’s trial activity reflects interest in the treatment setting after surgical management of colorectal liver metastases.
Clinical interest extends to the management of patients recovering from minor and major hepatic procedures, where postoperative liver function and disease-related outcomes are clinically relevant.
HepaRegeniX GmbH runs clinical trials in conditions such as Colon cancer, among others.
Clinical trials run by this sponsor – those enrolling participants first.
A study to evaluate the safety and effectiveness of darizmetinib hydrochloride in patients who have had liver surgery due to colon cancer metastases
FranceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
